Catalyst Wire Dossier Catalyst Wire Dossier

MUSKARDIA

Shexiang Baoxin Pill · Shanghai Hutchison Pharmaceuticals Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MUSKARDIA, covering 2025-09-04 to 2025-09-04. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction [Phase 4]

See pricing